(Q53544139)

15 May 2018

title

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. (English)

1 reference

15 May 2018

5

Tefferi A

1 reference

15 May 2018

Pardanani A

1

1 reference

15 May 2018

Lasho TL

series ordinal

2

1 reference

15 May 2018

Finke C

series ordinal

3

1 reference

15 May 2018

Hanson CA

series ordinal

4

1 reference

15 May 2018

publication date

28 June 2007

1 reference

15 May 2018

published in

Leukemia

1 reference

15 May 2018

volume

21

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

page(s)

1960-1963

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404810

exact match

0 references

cites work

Oncogenes in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

Cellular origin and lineage specificity of the JAK2(V617F) allele in polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

7 January 2021

inferred from DOI database lookup

Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

7 January 2021

inferred from DOI database lookup

Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404810

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.LEU.2404810

1 reference

15 May 2018

release_x7zaqj6z4fhjhodr7bfvxvaggy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x7zaqj6z4fhjhodr7bfvxvaggy

24 November 2022

mapped directly with Wikidata item

1 reference

15 May 2018